Coherus Biosciences OverviewCoherus Biosciences Net Income
Profitability analysis for CHRS.
Quarterly Net Income
-$37.94M
↑ 32.93% YoY
As of Mar 2026
Annual Net Income (TTM)
-$151.66M
↓ 15.83% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...